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Cerebrovascular lesions are frequently observed in patients with sickle-cell disease (SCD)
and these structural lesions are preceded by insidious perfusion deficits. Our aim was to
investigate the presence of brain perfusion deficits in neurologically asymptomatic SCD
patients, especially affecting microvessels. For this study, 42 SCD patients [33 sickle-cell
anemia (HbSS), 6 sickle hemoglobin C disease (HbSC), and 3 sickle β-thalassemia disease
(HbSβ)] with mean hematocrit of 25.1 (±4.85; 15.6–38.5) underwent brain perfusion single
photon emission computerized tomography (SPECT) using the tracer 99mTc-ECD. Images
from SCD patients were compared to images of a healthy control group (29 females and 20
males, mean age 31±8; range 25–49 years). Images underwent voxel-wise comparison of
regional tracer uptake using paired t -test to estimate the probability of each voxel to have an
increased or decreased tracer uptake. When compared to controls, SCD patients exhibited
significantly reduced tracer uptake in basal ganglia and thalami, the anterior frontal region
and the watershed region of the temporo-parietal-occipital transition (p<0.05). Our study
showed that neurologically asymptomatic adult SCD patients exhibit a pattern of reduced
99mTc-ECD tracer uptake demonstrated by SPECT. Early diagnosis of this cerebral vas-
culopathy has prognostic implications and can be determinant in considering therapeutic
alternatives to avoid increasing brain lesion load and progressive disability.
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INTRODUCTION
Severe hemolytic anemia, vascular occlusions, and cumulative
organ damage secondary to infarcts are frequently found among
the clinical manifestations of patients with sickle-cell disease
(SCD). Neurological dysfunction is a well-known complication in
patients with SCD. It is usually manifested as an acute cerebrovas-
cular accident, or alternatively as a headache, seizure, or cognitive
decline (1). Children and teenagers are particularly vulnerable to
overt cerebrovascular complications of SCD (2). Steen et al. have
shown that at an average age of 10 years, the estimated preva-
lence of vasculopathy in the homozygous for hemoglobin (Hb) S
(SS) patients detected by magnetic resonance imaging (MRI) was
64% (3).
The Cooperative Study of Sickle-Cell Disease (CSSCD) demon-
strated that the incidence rate of a first stroke by the age of 20 is
11% in SS patients (4, 5). While younger patients tended to have
occlusive strokes, hemorrhagic strokes were more common in the
20–29 year old patients. The CSSCD also analyzed structural MRI
from 312 patients, and reported that ischemic lesions were present
in 13% of all SCD patients without a clinical history of overt
stroke. These “silent infarcts” have been shown to be associated
with neuropsychological decline, progressive brain injury, and are
a significant risk factor for overt stroke in SCD patients (6, 7).
Currently, the screening for silent cerebrovascular disease in
patients with SCD is performed by a combination of tech-
niques including visual inspection of structural MRI, transcranial
Doppler (TCD) and MR angiography (MRA) (8). A follow-up
study by Seibert et al. (9) demonstrated that an abnormal MRA is
highly predictive of stroke in asymptomatic patients with SCD, and
suggested that screening for cerebrovascular disease should be per-
formed first with TCD and followed by MRA if the TCD reveals any
abnormality. However, this combination of techniques may occa-
sionally fail to detect cerebrovascular abnormalities, especially at
the microvascular level. Wang et al. (10) examined 78 asympto-
matic children with SCD and observed that the structural MRI
and TCD are often discordant, suggesting the need for a more sen-
sitive and specific indicator of early cerebrovascular dysfunction.
Indeed, TCD is not a reliable method to screen for silent infarcts.
It is limited to the evaluation of cerebral blood flow (CBF) velocity
of large arteries while silent infarcts are routinely found in patients
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with normal CBF velocity (10). Likewise, structural MRI may not
be able to assess the status of the microcirculation where the sick-
led red blood cells obstruct the blood flow leading to regional
ischemia and progressive organ injury without necessarily causing
detectable structural abnormalities at the scale measured by this
tool (11).
Perfusion and metabolic imaging techniques such as positron
emission tomography (PET) have been used to investigate the
microvascular blood flow in patients with SCD. Powars et al. (12)
used PET to detect abnormalities missed by structural MRI in
patients with SCD and a history of stroke and Reed et al. found a
metabolic compromise that extended beyond any corresponding
anatomic abnormality demonstrated on MRI (13). Perfusion MRI
has also been used to assess CBF in asymptomatic SCD children
with results depicting reduced perfusion in areas appearing to be
normal on conventional MRI (14). Neurological complications
due to microvascular compromise in SCD are still underesti-
mated, and structural lesions are preceded by insidious perfusion
deficits (15).
Single photon emission computerized tomography (SPECT) is
a functional neuroimaging technique that allows a non-invasive
evaluation of the physiological and pathophysiological status of
the brain (16). Ethyl-cysteinate-dimer labeled with technetium-
99 m (99mTc-ECD) is a lipophilic compound that crosses the blood
brain barrier, entering the neuronal cell where it is converted to
a hydrophilic form, remaining trapped inside the cell. The dis-
tribution of this tracer in the brain is proportional to regional
cerebral blood flow (rCBF). However, 99mTc-ECD is a perfusion
agent that demands a metabolic process of desertification inside
the cell and is therefore an indirect indication of metabolism (15)
PET imaging is characterized by a higher resolution, sensitivity
and can be quantified in absolute units. However, SPECT is easier
to perform as a routine procedure due to its lower cost, simplicity,
and availability.
To investigate the hypothesis of an insidious brain perfusion
compromise in SCD patients, a voxel-based analysis of 99mTc-ECD
SPECT images of the whole brain of neurologically asymptomatic
adult patients with SCD was performed. Tracer uptake of SCD
patients and tracer uptake in a group of neurologically healthy
controls that did not suffer from SCD were compared to identify
areas with abnormal perfusion.
MATERIALS AND METHODS
SUBJECTS AND CLINICAL ASSESSMENT
Forty-two patients with SCD from the hemoglobinopathy out-
patient clinics of the State University of Campinas Hematology
and Hemotherapy Center (Hemocentro/UNICAMP), distributed
as 27 females and 15 males with mean age of 33.4 years (± 10.55,
range 18–60) were included in this study. The inclusion criteria
were to be at least 18 years old, a clear clinical and laboratory diag-
nosis of any SCD and being available for regular follow-up. The
laboratory diagnosis of SCD was based on Hb electrophoresis and
genetic testing. The 42 patients had no neurological symptoms
during the time of investigation. They were thoroughly examined
by a neurologist upon their enrollment to exclude any unsuspected
neurological disorder. They were submitted to a structural MRI
of the brain to exclude any gross intracranial pathology. Systemic
arterial hypertension, cancer, diabetes, vasculitis, pregnancy,AIDS,
or any other relevant medical condition were exclusion criteria for
this study.
The SCD types were distributed as follows: 33 HbSS (14 males
and 19 females), 6 HbSC (1 male and 5 females), and 3 HbSβ (3
females). The mean steady state Hb level measured in the period of
up to 2 weeks before or after imaging acquisition was 8.5 (±1.73;
5.2–13.5) and the mean hematocrit was 25.1 (±4.85; 15.6–38.5).
The group of patients with SCD was compared to a group
of healthy control subjects (29 females and 20 males, mean age
31± 8; range 25–49 years) recruited within the local community,
who were submitted to the same imaging protocol used in the SCD
patients.
This study was approved by the Ethical Committee of our
institution and informed consent was obtained from all patients.
SPECT IMAGING
To perform brain perfusion SPECT, patients rested supine in a
dark, quite room for 30 min before injection. To reduce brain
stimuli, the patients had an intravenous catheter placed prior to
tracer injection for the infusion of 0.9% saline solution at a slow
rate. The patients were then injected with 1100 MBq of the rCBF
SPECT tracer 99mTc-ECD intravenously and remained at rest for
15–20 additional minutes. Image acquisition started 30 min post
injection with a single headed scintillation camera (APEX SP6
ELSCINT, Haifa, Israel), equipped with a fan-beam collimator.
Sixty views were acquired every 6° in a 360° fixed circular orbit
around the patients’ heads (64× 64 matrix, 30 s per view). Images
were reconstructed by filtered backprojection and Metz filter-
ing (FWHM= 14 mm). Attenuation correction was performed by
Chang first order method (attenuation coefficient= 0.115 cm−1).
Reconstructed transaxial images were reformatted and displayed
as sagittal, axial, and coronal sections.
PREPROCESSING OF SPECT IMAGES
Reconstructed transaxial datasets were transformed into ANA-
LYZE using MRIcro software (Chris Rorden1). Voxel-based analy-
sis was performed using SPM2 (Wellcome Department of Cogni-
tive Neurology2). Images were spatially normalized to a standard
anatomical template using linear transforms followed by 16 non-
linear iterations with medium regularization. After normalization,
the images were convolved with an Isotropic Gaussian Kernel
(FWHM) of 10 mm to minimize gyral inter-individual variabil-
ity and create images that are more normally distributed thus
permitting voxel-wise analysis. The normalized smoothed images
underwent between group comparisons of regional tracer uptake
by using paired t -tests. Contrasts were defined to estimate the
probability of each voxel to have an increased or decreased tracer
uptake in images from patients with SCD compared to images
from the control group (17, 18).
STATISTICAL ANALYSIS
Group differences for age were assessed using one-way ANOVA,
and the gender distribution was evaluated with the Chi square test.
1www.mricro.com
2http://www.ucl.ac.uk/ion/departments/repair/themes/cognitive
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The normalized and smoothed data was analyzed using SPM2.
SPECT images from patients with SCD were compared to the
SPECT images of normal controls using two-sample t -test. The
99mTc-ECD uptake was standardized to the mean global uptake
using proportional scaling. Only voxels with signal intensities
above a gray matter threshold of 0.8 were entered in each analy-
sis. The results from the analysis are a parametric map of t -
statistic [SPM(t)] corrected for normal distribution [SPM(z)]. The
statistical threshold was a false discovery rate (FDR) corrected
p< 0.05 (19) with an extent threshold looking for clusters with at
least 32 contiguous voxels (Height threshold: T = 2.67).
RESULTS
The values of the t -statistic [SPM(t)] and [SPM(z)] are displayed in
Table 1, showing the regions of reduced tracer uptake in patients
with SCD. Regions of tracer uptake excess in patients with SCD
Table 1 | Results of the voxel-based comparison of SPECT images between controls and SCD patients.
























x, y, z (mm)
Right rostral cerebellar cortex 0.045 8485 0.013 >0.001 6.27 5.69 >0.0001 17, −80, −50
Medial occipital cortex 0.001 5.38 4.99 >0.001 −0, −86, −12
Left rostral cerebellar cortex 0.002 4.71 4.44 >0.0001 −18, −80, −50
Left frontal pole 0.271 3488 0.092 >0.001 5.84 5.36 >0.001 −42, 47, −17
Left ventral prefrontal cortex 0.001 5.58 5.15 >0.0001 −42, 39, −20
Left anterior ventral prefrontal
cortex
0.001 5.09 4.75 >0.0001 −35, 44, −18
Left upper dorso-lateral
fronto-parietal transition
0.021 10899 0.006 >0.001 5.77 5.3 >0.0001 −15, −39, 81
Upper medial fronto-parietal
region
0.001 5.22 4.86 >0.001 −2, −36, 81
Left upper aspect of central
sulcus
0.001 5.15 4.8 >0.0001 −15, −29, 81
Posterior horn of right lateral
ventricle/temporo-parietal-
occipital transition
0.001 21018 >0.001 0.001 5.3 4.93 >0.0001 21, −36, 20
Fornix/Central Forebrain 0.001 5.29 4.91 >0.001 −20, 0, 12
Left anterior frontal region 0.001 5.07 4.74 >0.001 −21, 18, 20
Upper dorsal aspect of left
precentral gyrus
0.88 320 0.615 0.007 4.03 3.85 >0.0001 −44, −18, 66
Upper dorso-lateral aspect of
left precentral gyrus
0.01 3.76 3.61 >0.0001 −48, −24, 63
Left superior parietal gyrus 0.954 34 0.897 0.013 3.55 3.42 >0.001 −30, −62, 68
Fourth ventricle/upper aspect
of vermis
0.861 391 0.574 0.025 3.14 3.05 0.001 −2, −41, −24
Upper aspect of right
temporopolar cortex
0.901 237 0.672 0.029 3.04 2.95 0.002 36, 15, −21
Left superior frontal sulcus 0.939 89 0.813 0.033 2.97 2.89 0.002 −27, 27, 56
Right insula 0.938 91 0.811 0.037 2.89 2.82 0.002 45, −3, 8
The table outlines the anatomical locations where reduced 99mTc-ECD tracer uptake was observed in patients with SCD. Each anatomical location is followed by the
display of the corresponding p-values and the cluster size in voxels of the cluster of contiguous voxels that was observed to show reduced perfusion. Each location is
also followed by the t-statistic [SPM(t)] corrected for normal distribution [SPM(z)] of the analysis performed with individual voxels. Finally, the stereotaxic coordinates
for the anatomical locations is displayed. A Height threshold: T=2.67, p=0.004 (0.968), was used, with p-values adjusted for the number of voxels contained within
the entire volume.We restricted the analysis to voxels that belonged to clusters with at least 32 voxels.
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FIGURE 1 | Parametric map of the t -statistic [SPM(t)] depicts the location
and the statistical significance of voxels with a significant probability of
decreased tracer uptake and therefore reduced blood flow in patients
with SCD compared to controls. The map is illustrated in a “glass brain
template” in radiological convention (i.e., the left side of the brain is displayed
in the right side of the image). The statistical threshold was set at p<0.05
looking for clusters with at least 32 contiguous voxels, corrected by multiple
comparisons using FDR.
were not observed in comparison to controls. The three dimen-
sional rendering of the parametric map of t -statistic was over-
laid in a normal brain perfusion SPECT template as shown in
Figure 1.
A widespread reduced tracer uptake, corresponding to reduced
blood flow was found in patients with SCD when compared to nor-
mal controls. In summary, we observed hypoperfusion involving
the cerebellar hemispheres and vermis, the frontal and prefrontal
cortex, especially the left, the fronto-parietal transition, the poste-
rior periventricular region, the temporo-parietal-occipital transi-
tion, the central forebrain, and the ventral aspect of basal ganglia
and thalami.
DISCUSSION
Our results demonstrate that neurologically asymptomatic adult
SCD patients exhibit brain perfusion abnormalities in areas pri-
marily supplied by small and terminal branches of arterial blood
vessels. Specifically, we observed a decreased tracer uptake in the
basal central forebrain, including the basal ganglia and thalami,
watershed areas of the anterior circulation and cerebellar and
occipital cortex. These findings may contribute to the under-
standing of mechanisms underlying the evolution of cerebral
vasculopathy of SCD patients.
Silent cerebral vasculopathy in SCD patients is a major topic
of research because it is strongly associated with increased stroke
risk and progressive cognitive decline (20). Wang et al. (19) have
recently demonstrated psychometric decline in performance with
age in SCD patients with normal MRI, indicating brain dysfunc-
tion in SCD patients even when no structural damage is detected
by MRI (21). A recent systematic review has shown that perfusion
compromise precede the structural changes and TCD abnormal-
ities usually found in SCD patients and therefore the assessment
of cerebral blood perfusion can be of potential value in addressing
brain abnormalities at the tissue level (22).
Significant hypoperfusion in the basal ganglia and thalami was
found in the present study. These areas have already been described
as frequent sites of ischemic damage in SCD patients. Pegelow
et al. (23) evaluated 47 neurologically normal SCD children with
MRI and found a total of 129 lesions; of these, 14 lesions were in
the thalami and basal ganglia. In the CSSCD 27% of the patients
with MRI abnormalities were found to have lesions in the thal-
amus and basal ganglia (23). Our results complement research
showing the caudate, thalamus, and cortex as areas of selective
vulnerability to damage in SCD patients (24). The hypoperfusion
we observed in the thalamus and basal ganglia is possibly an addi-
tional factor accounting for the development of cognitive decline
in SCD patients. Similar to vascular dementia (25), the slowness
of mental labor, attention deficits, and dysfunction of working
memory found in SCD patients could be attributed in part to dis-
ruption of thalamic function and interruption of thalamocortical
connections.
We observed hypoperfusion in the frontal lobes, especially
in medial areas. These regions are also recognized as frequently
damaged in SCD patients. Studies using PET to evaluate brain
perfusion in SCD patients have previously demonstrated hypome-
tabolism in frontal areas and hypoperfusion in areas that appear
to be normal on structural MRI (12, 26, 27). Pegelow et al. (28)
performed a longitudinal assessment of MRI changes on the
brains of SCD patients and observed that the frontal lobe was
the most frequent location of ischemic damage in both neuro-
logically asymptomatic and patients with a previous stroke (28).
Frontal lobe lesions were detected in 81% of the children with
silent infarcts and in 94.4% of those with a history of prior stroke.
This finding suggests an early involvement of the frontal lobes in
SCD brain vasculopathy and this may be an important predic-
tive factor for overt stroke, since children with silent infarcts were
significantly less likely to have lesions in the frontal cortex, as com-
pared to patients with a history of a previous stroke. These findings
are in accordance with the results of the work of Balci et al. (29)
whom have found microstructural abnormalities of various brain
areas in SCD patients using diffusion-tensor imaging.
We recognized low tracer uptake in cerebellum, interestingly
affecting the cerebellar hemisphere contralateral to the most
hypoperfused cortical hemisphere. This hypoperfusion may result
from functional disconnection of the contralateral cerebellar neu-
rons from their correspondent cerebral neurons. Interruption
of the cerebropontine-cerebellar pathway is thought to be the
most likely mechanism of this remote transneuronal metabolic
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depression known as diaschisis (30) and SPECT is a sensitive
method for detecting this crossed cerebellar hypoperfusion (31).
Single photon emission computerized tomography imaging is
a low-sensitivity method to white matter perfusion. The SPECT
tracer distribution has a gray matter to white matter 4:1 ratio, and
as a consequence cortical hypoperfusion is more accurately visu-
alized. In this study we observed clusters of hypoperfused areas
in patients with SCD that spanned over subcortical white mat-
ter, especially in the temporo-parietal-occipital transition. These
findings are possibly a reflection of a widespread reduction of per-
fusion affecting the surrounding gray matter. These findings may
improve our understanding of the progression of SCD brain vas-
culopathy. The observed reduction of tracer uptake may reflect
ischemia, hypometabolism or both (15). Patients with SCD are
chronically anemic and this condition increases the CBF due to
hemodilution and as a compensatory response to decreased oxy-
gen delivery (3). However, this hyperemic status predisposes to
turbulent blood flow and subsequent endothelial cell injury, lead-
ing to hemodynamic shear stress and vessel wall damage (1, 32).
Besides that, erythrocytes having HbS are very sensitive to oxy-
gen saturation reduction. Polymerization of deoxygenated HbS
is the initial step of a multifactorial, heterocellular event, causing
erythrocyte sickling in the microvasculature and subsequent adhe-
sion of these cells to endothelium which triggers a vast array of
vascular microenvironmental modifications (33). This sickle-cell-
induced vaso-occlusion is a very complex process and involves
the participation of vascular cell adhesion molecules, especially
VCAM-1, proinflammatory cytokines, leukocytes, and other active
metabolites, all contributing to the enhanced cell-endothelium
adherence (34).
Coupling of blood flow and metabolism is the most important
control of the cerebral circulation. Neuronal activation increases
the consumption of glucose and oxygen and therefore induces an
increase in CBF in order to accommodate this metabolic demand
(35). However, in SCD patients, these auto-regulatory mechanisms
might be compromised due to progressive vascular damage sec-
ondary to repetitive sickling (1, 24). This auto-regulatory failure
is even more significant in hypoxemic conditions, in which the
expected cerebral vasodilation response may not occur as it might
already be exhausted (36, 37). We speculate that the observed
hypoperfusion results from a mixture of vaso-occlusion leading
to ischemia, vascular auto-regulatory failure, and selective tissue
damage secondary to an insufficient oxygen delivery in high meta-
bolic states. A form of non-erythroid globin found in some areas
of the brain (brain Hb) has been described as a source of oxygen
in states of hypoxemia and may then act to provide a homeo-
static mechanism in anoxic conditions of high metabolic areas.
This mechanism could play a role in protecting the tissue at risk
(38). As presumed to occur in some neurodegenerative diseases, we
could also consider the possibility of a malfunctioning interaction
linking brain Hb expression to mitochondrial function in SCD
patients leading to neuronal damage or dysfunction. The hypop-
erfusion detected in the occipital lobes is an important illustration
of damage in a region of high metabolism since visual stimuli are
important determinants of neuronal activation.
Sickle-cell disease patients have a wide Hb range, from nor-
mal to severely anemic, and it is likely that the lower the level
of Hb the more intense the hemolysis reflecting a more active
sickling pattern and, therefore, more likely to influence brain per-
fusion and to provoke brain ischemia. However, it was not within
the scope of our study to compare the abnormalities between
groups with higher and lower levels of Hb, since our purpose was
to analyze brain perfusion in SCD patients without neurological
symptoms.
In conclusion, we observed an anatomical pattern of regional
decreased brain perfusion in asymptomatic patients with SCD
using 99mTc-ECD SPECT. Specifically, we observed hypoperfusion
in regions supplied by microvessels. We suggest that these brain
areas may be more susceptible to insidious and silent brain injury
due to SCD vasculopathy. These findings could have a prognostic
application and offer a reliable measure for evaluating treatments
designed to reduce the incidence of brain lesions and cognitive
dysfunction in SCD patients.
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